Overall, the most common AE (reported by two or more subjects) were increases in liver enzymes alanine aminotransferase (ALT) or aspartate aminotransferase (AST), cough, headache, hyperglycemia, injection site pain, nasopharyngitis, oropharyngeal pain and rhinorrhea. This evidence concerns the gene GPT and nasopharyngitis.